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Scheme S1. Synthesis of 3-decanoyl-5-methyltetramic acid analogues Figure S1 . Chemical structure of 3-oxo-C 12 -HSL 1 highlighting the structural units targeted for the SAR study. Table S1 . QS and growth inhibitory activities of other 3-oxo-C 12 -HSL analogues 
Acyl chain S14
6-Cy-3-oxo-C 6 -HSL --*no growth inhibition up to 100 µM; **no inhibition of agr observed at concentrations up to 100 µM 
S7
--*no growth inhibition up to 100 µM; **no inhibition of agr observed at concentrations up to 100 µM.
S8
Chemical synthesis and characterization of N-acylhomoserine lactone analogues
General information
The starting materials were purchased from Aldrich Chemical Co. 3-Oxododecanoic acid (prepared from methyl 3-oxododecanoate by saponification at room temperature) (0.348 g, 1.63 mmol), dry DCM (40 ml), DMAP (0.298 g, 2.45 mmol), and α-hydroxy-γ-butyrolactone (0.166 g, 1.63 mmol) were stirred at room temperature under nitrogen. DCCI (0.386 g, 1.87 mmol) was added and the mixture was stirred overnight at room temperature. The mixture was filtered to remove precipitated DCU and the filtrate was washed with 1 M HCl (2 x 10 ml), saturated sodium bicarbonate (2 x 10 ml), and brine (10 ml). The organic layer was dried over magnesium sulphate and concentrated to dryness to give an oily white solid. The oily solid was triturated with hexane and purified using Flash chromatography (30% ethyl acetate in hexane followed by 100% ethyl acetate) to deliver the title compound S13 as a white solid (0.103 g, 21% 
Ethyl trans-4-decenoate (1.0 g, 5.0 mmol) in methanol (2 ml) was treated with a solution of NaOH (0.5 g, 12.5 mmol) in water (5 ml) and stirred overnight at room temperature. The methanol was removed under reduced pressure. The aqueous solution was washed with ethyl acetate and then acidified with 1 M HCl (10 ml). The product was extracted with DCM (2 x 10 ml) and the pooled extract dried over magnesium sulphate and concentrated to dryness to give trans-4-decenoic acid as clear oil (0.743 g, 87%).
Using trans-4-decenoic acid, trans-4-decenoyl Meldrum's acid was prepared by a procedure similar to that described for acylated Meldrum's acid by Chhabra et al. trans-4-Decenoyl Meldrum's acid (0.528 g, 1.78 mmol), L-homoserine lactone HCl (0.245 g, 1.78 mmol), triethylamine (0.180 g, 1.78 mmol) and acetonitrile (20 ml) were stirred for 72 h at room temperature. The mixture was heated at reflux for 2 h and then the solvent was removed under reduced pressure. The residue was taken up in ethyl acetate (20 ml) and insoluble inorganics were removed by filtration. The filtrate was washed with saturated sodium bicarbonate (2 x 10 ml), 1 M HCl (2 x 10 ml) and brine (10 ml). The solution was dried over magnesium sulphate and concentrated to dryness to give a cream/white solid which was recrystallised from ethyl acetate/hexane to give the title compound S14 as an off white solid (0.196 g, 37%).
[α] D = +5.9 (c = 1.53, CHCl 3 ). 1 
N-(3-Oxo-6-phenylhexanoyl)-L-homoserine lactone (6-Ph-3-oxo-C 6 -HSL) S15
The title compound was prepared using 4-phenylbutyric acid and following the procedure described for S14. The crude oily solid was purified using silica plate chromatography (50% toluene in acetone) and then by trituration with ether to give S15 as a white solid (0.155 g, 29%).
[α] D = +15. 
N-(3-oxo-6-cyclohexylhexanoyl)-L-homoserine lactone (6-Cy-3-oxo-C 6 -HSL) S16
The title compound was prepared using 4-cyclohexylbutyric acid and following the procedure described for S14. The crude off white solid was purified using flash chromatography (90% ethyl acetate in hexane) and trituration with ether to give S16 as a white solid (0.226 g, 40% 
S11
Chemical synthesis and characterization of 3-acyltetramic acid (TMA) analogues 
S14
The 3-acyl-5-alkyltetramic acids 12 and 13 were prepared as shown in the Scheme 2. 
5-(N-tert-Butoxycarbonylalanyl) Meldrum's acid N-tert-Butoxycarbonyl-L-alanine (Boc-Ala-OH)
(0.378 g, 2 mmol), dry DCM (20 ml), DMAP (0.366 g, 3 mmol), and Meldrum's Acid (0.302 g, 2.1 mmol) were stirred at room temperature under nitrogen. DCCI (0.473 g, 2.3 mmol) was added and the mixture was stirred overnight at room temperature. The mixture was filtered to remove the precipitated DCU and the filtrate was washed with 1 M KHSO 4 (2 x 15 ml). The organic layer was dried over magnesium sulphate and concentrated to dryness. The resulting yellow oily solid was suspended in cold acetone (2 ml) and filtered to remove the insoluble solid. The filtrate was concentrated to dryness to give 5-(Ntert-butoxycarbonylalanyl) Meldrum's acid as a yellow oil (0.50 g, 79% 
N-Boc-5-methyltetramic acid
A solution of 5-(N-tert-butoxycarbonylalanyl) Meldrum's acid (0.490 g) in ethyl acetate (100 ml) was heated at reflux for 30 min. The solution was cooled to room temperature, washed with 1 M KHSO 4 (2 x 10 ml) and brine (10 ml) before being dried over magnesium sulphate and concentrated to dryness to give N-Boc-5-methyltetramic acid as a pale yellow solid (0.280 g, 85%). 
5-N-tert-Butoxycarbonyl-3-decanoyl-5-methyltetramic acid
A solution of N-Boc-5-methyltetramic acid (0.173 g, 0.811 mmol), DMAP (0.148 g, 1.217 mmol), and decanoic acid (0.139 g, 0.811 mmol) in dry DCM (20 ml) was stirred at room temperature under nitrogen. Triethylamine (0.164 g, 1.62 mmol) and DCCI (0.192 g, 0.933 mmol) were added and the mixture was stirred overnight at room temperature. The mixture was filtered to remove insoluble DCU and the filtrate was washed with 1 M KHSO 4 (2 x 15 ml). The organic layer was dried over magnesium sulphate and concentrated to dryness. The resulting yellow oily solid was suspended in cold acetone (1 ml) and filtered to remove the remaining insoluble DCU. The filtrate was concentrated to dryness to give 5-N-tert-butoxycarbonyl-3-decanoyl-5-methyltetramic acid as a yellow oil (0.228 g, 77% 
3-Decanoylltetramic acid (C10-TMA) 13

NH O OH O
5-(N-tert-Butoxycarbonyglycyl) Meldrum's acid
A solution of N-tert-butoxycarbonylglycine (Boc-Gly-OH) (0.35 g, 2 mmol), DMAP (0.366 g, 3 mmol), and Meldrum's acid (0.302 g, 2.1 mmol) in dry DCM (20 ml) was stirred at room temperature under nitrogen. DCCI (0.473 g, 2.3 mmol) was added and the mixture was stirred overnight at room temperature. The mixture was filtered to remove insoluble DCU and the filtrate was washed with 1 M KHSO 4 (2 x 15 ml). The organic layer was dried over magnesium sulphate and concentrated to dryness. The resulting yellow oily solid was purified by dissolving in cold acetone (2 ml) and filtered to remove any remaining insoluble DCU. The filtrate was concentrated to dryness to give 5-(N-tert-butoxycarbonyglycyl) Meldrum's acid as yellow oil (0.463 g, 78%). CDCl 3 ) δ 1.39 (9H, s, CMe 3 ), 1.77 (6H, s, CMe 2 ), 4.69 (2H, d, NHCH 2 ) , 5.14 (1H, br s, NH), 15.69 (1H, br s, enolic OH).
H NMR (
N-Boc-tetramic acid
A solution of 5-(N-tert-butoxycarbonyglycyl) Meldrum's acid (0.461 g) in ethyl acetate (100 ml) was heated at reflux for 30 min. The solution was cooled to room temperature, washed with 1 M KHSO 4 (2 x 10 ml) and brine (10 ml) before being dried over magnesium sulphate and concentrated to dryness to give N-Boc-tetramic acid as a white solid (0.285 g, 93%). CDCl 3 ) δ 1.58 (9H, s, CMe 3 ) , 3 .27 (2H, s, COCH 2 CO), 4.27 (2H, s, COCH 2 N).
H NMR (
N-tert-Butoxycarbonyl-3-decanoyltetramic acid
A solution of N-Boc-tetramic acid (0.280 g, 1.41 mmol), DMAP (0.256 g, 2.1 mmol), and decanoic acid (0.241 g, 1.41 mmol) in dry DCM (20 ml) was stirred at room temperature under nitrogen. Triethylamine (0.28 g, 2.8 mmol) and DCCI (0.33 g, 1.62 mmol) were added and the mixture was stirred overnight at room temperature. The mixture was filtered to remove insoluble DCU and the filtrate was washed with 1 M KHSO 4 (2 x 15 ml). The organic layer was dried over magnesium sulphate and concentrated to dryness. The resulting yellow oily solid was suspended in cold acetone (1 ml) and filtered to remove any remaining insoluble DCU. The filtrate was concentrated to dryness to give an orange oil which was further purified using Flash chromatography (50% ethyl acetate in hexane) to give N-tert-butoxycarbonyl-3-decanoyltetramic acid as a glassy solid (0.138 g, 28%). A solution of N-tert-butoxycarbonyl-3-decanoyltetramic acid (0.135 g) in DCM (5 ml), water (0.1 ml) and TFA (5 ml) were stirred at room temperature for 2 h. The solvent was removed under reduced pressure with the aid of acetonitrile to give a brown oil (0.145 g), which was purified by trituration with ether and hexane to give the title 3-decanoylltetramic acid 13 as a cream solid (0.073 g, 75% 
Chemical synthesis and characterization of 3-acyltetronic acid (TOA) analogues
The 3-acyltetronic acids were prepared by the General Procedure 2 (GP2) as shown in Scheme 3 by acylation of the commercially available tetronic acid [4-hydroxy-2(5H)-furanone] essentially by the procedure described by Nomura et al. 
General Procedure 2 (GP2)
N,N'-Dicyclohexylcarbodiimide (DCCI) (2.3 mmol) was added to a stirred solution of alkanoic acid (2 mmol) and 4-(dimethylamino)pyridine (DMAP) (3 mmol) in dry dichloromethane (20 ml) at room temperature under nitrogen. Tetronic acid (2.1 mmol) was added and the mixture was stirred overnight at room temperature. The mixture was filtered to remove insoluble N,N'-dicyclohexylurea (DCU) and the filtrate was extracted with 1 M HCl (2 x 10 ml). The organic layer was dried over magnesium sulphate and concentrated to dryness to give 3-acyltetronic acids as solids. A solution of isobutyryl chloride (5.25 g, 0.0492 mol) in dry chloroform (10 ml) was added to a mixture of 1-morpholinocyclohexene (7.9 g, 0.0472 mol), triethylamine (5.16 g, 0.606 mol) in chloroform (35 ml) over 30 min at room temperature. The slurry formed was stirred overnight at room temperature. 20% Aqueous HCl (25 ml) was added and the mixture was heated at reflux for 5 h. The solution was cooled and the aqueous layer was removed and the pH was checked to ensure it remained acidic. The organic layer was washed with saturated NaHCO 3 (2 x 20 ml) and brine (20 ml), dried over magnesium sulphate and concentrated to dryness to give the crude diketone, 2-isobutyrylcyclohexanone as an orange oil (6.791 g).
3-Hexanoyltetronic acid
The crude diketone was refluxed with a solution of NaOH (6.0 g, 0.15 mol) in water (10 ml) for 1 h. The mixture was cooled and poured into ice water (50 ml) and acidified with conc. HCl (14 ml) to pH 1-3. The aqueous solution was extracted with DCM (2 x 25 ml) and the combined extracts were washed with brine (25 ml), dried over magnesium sulphate and concentrated to dryness to give crude product as a brown oil (4.876 g). This was purified by high vacuum (1 to 2 mbar) distillation to give pure 8-methyl-7-oxononanoic acid as a yellow oily solid (3.1 g). 
8-Methylnonanoic acid
A solution of 8-methyl-7-oxononanoic acid (4.5 g, 0.0242 mol), hydrazine monohydrate (7.71 ml) and potassium hydroxide pellets (1.59 g, 0.0242 mol) in diethylene glycol (23 ml) were heated at reflux for 7 h. Another lot of potassium hydroxide pellets (7.98 g, 0.121 mol) and diethylene glycol (23 ml) were added to the mixture and further heated at reflux overnight. The mixture was cooled to room temperature and poured into ice water (400 ml) and acidified to pH 1-2 with conc. HCl (25 ml). The resulting white solid was collected by filtration and washed with water (4 x 10 ml) to furnish 8-methylnonanoic acid (3.14 g, 75% 
3-[(E)-4-Decenoyl]tetronic acid (Δ
The use of trans-4-decenoic acid (described as for S14) in GP2 gave S18 as a pale yellow solid in 65% yield. 
